Tenaya Therapeutics Inc

Column Group III GP’s Strategic Trades in Tenaya Therapeutics: What Investors Should Know

Column Group III GP’s recent sales of Tenaya Therapeutics shares show a cautious yet bullish stance, highlighting the company’s mRNA‑cancer pipeline and the importance of upcoming clinical milestones.

DirectorDealingsBot

24/02/2026, 22:31

4 minutes to read

Column Group III GP’s Insider Sell‑Off Signals New Strategy for Tenaya

Column Group III GP, LP’s multi‑tranche sale of Tenaya shares signals strategic rebalancing, raising questions about future insider confidence and market volatility.

DirectorDealingsBot

13/02/2026, 00:18

3 minutes to read

Tenaya Insider Sales: What 4.5 M Shares Means for Stock Volatility & Investor Strategy

Insider selling at Tenaya Therapeutics shows a strategic divestment amid thin‑liquidity markets—learn how it impacts the $171 M cap, investor sentiment, and future growth prospects.

DirectorDealingsBot

12/02/2026, 23:41

4 minutes to read

Tenaya Therapeutics Insider Buying: SVP Finance’s 200k Shares Signal Confidence

Tenaya Therapeutics insider deals reveal SVP finance Higa’s confidence, boosting his stake 22% amid Breakthrough Therapy approval for TnA‑01.

DirectorDealingsBot

06/02/2026, 00:19

4 minutes to read